Drugs / Dachengqi Decoction
Dachengqi Decoction
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04517045 | Oct 2020 → Jul 2022 | — | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06948474 | Aug 2024 → Mar 2026 overdue | — | China-Japan Friendship Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dachengqi decoction | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06948474 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Chinese medicine formula Dachengqi Decoction” NCT06948474 ↗ |
| Route | Other | “fed via nasogastric tube/nasal intestine tube and enema” NCT04517045 ↗ |
| Route | Rectal | “fed via nasogastric tube/nasal intestine tube and enema” NCT04517045 ↗ |